Multifunctional Chromatography Medium for Biologic Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current purification processes for biologics, particularly monoclonal antibodies, struggle to efficiently remove process- and product-related impurities, such as antibody fragments and aggregates, due to limitations in chromatographic technologies.
Innovation Solution
A multifunctional chromatography medium comprising porous beads or particles with a defined pore diameter distribution and ligands conjugated to the surface, enabling the capture of impurities while allowing the target biologic to flow through unbound.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If ion-exchange and hydrophobic interaction chromatography are used to isolate the product from impurities, then purification is achieved, but the process is limited by subtle differences in charge or amphiphilicity and cannot robustly clear antibody fragments
Solution Approach 1:
The patent applies mixed-mode chromatography that combines multiple mechanisms (ion-exchange, hydrophobic interaction, and size exclusion) into a single chromatography medium. This multi-functional approach enables the system to remove diverse impurities including antibody fragments, aggregates, and host cell proteins through different binding mechanisms simultaneously, rather than requiring separate steps for each impurity type.
Solution Approach 2:
The chromatography medium employs composite material design by integrating multiple ligand types and pore structures within a single bead or monolith. The medium contains both charged groups for ion-exchange and hydrophobic regions for hydrophobic interaction, creating a composite functional material that addresses multiple purification challenges in one step.
2Manufacturing precision
If bind-and-elute mode chromatography is used, then product isolation is achieved, but the process complexity and operational costs increase
Solution Approach 1:
The patent employs flow-through mode chromatography where impurities are selectively captured and retained on the chromatography medium while the target product flows through unchanged and is immediately collected. This extracts the impurity removal function from the main product stream, eliminating the need for complex binding and elution steps required in traditional modes.
Solution Approach 2:
The flow-through mode enables continuous processing where the chromatography column operates without interruption - sample is continuously loaded, impurities are continuously captured, and purified product is continuously collected. This continuous operation simplifies the process compared to batch bind-and-elute cycles and reduces operational complexity.
3Manufacturing precision
If traditional chromatography media are used, then purification is achieved, but capital and operational costs remain high
Solution Approach 1:
The patent merges multiple purification functions (ion-exchange, hydrophobic interaction, size exclusion) into a single chromatography step. By combining what would traditionally require multiple sequential chromatography steps into one medium, the process reduces capital equipment requirements and operational costs while maintaining high purification quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described chromatography medium effectively removes both process- and product-related impurities, achieving high yields and purities of the target biologic, with the potential to reduce operational costs and simplify downstream processing.
Implementation Method 1
one or more ligands functionalized to surfaces of the pores... the one or more ligands are configured to bind or associate with at least one impurity in the sample
Data Source
AI summary
The present disclosure provides methods related to the purification of a biologic. In particular, the present disclosure methods for purifying a biologic using a multifunctional chromatography medium comprising porous beads or particles having a defined pore diameter distribution and one or more ligands conjugated to the surface of the pores capable of removing process-related impurities and product-related impurities from a target biologic.